William L. Macias
Hoofd Techniek/Wetenschap/O&O bij IMMUNOVANT, INC.
Vermogen: 10 M $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van William L. Macias
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 24 | |
Lilly Research Laboratories
 Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a company that engages in research and develops medicines. The company is based in Indianapolis, IN.
9
| Subsidiary | Miscellaneous Commercial Services | 9 |
Immunetrics, Inc.
 Immunetrics, Inc. BiotechnologyHealth Technology Immunetrics, Inc. operates as a bio-simulation company. The company was founded by Carson Chow, Timothy R. Billiar, Gilles Clermont, Mitchell P. Fink and Yoram Vodovotz in 2001 and is headquartered in Pittsburgh, PA.
3
| Subsidiary | Biotechnology | 3 |
PROMETHERA Biosciences SA
 PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
1
| Holding Company | Pharmaceuticals: Major | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met William L. Macias via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| IMMUNOMEDICS, INC. | Biotechnology | Investor Relations Contact Chief Tech/Sci/R&D Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Treasurer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Human Resources Officer Corporate Officer/Principal Corporate Officer/Principal | |
| ATHENAHEALTH, INC | Packaged Software | Corporate Officer/Principal | |
NeoTract, Inc.
 NeoTract, Inc. BiotechnologyHealth Technology NeoTract, Inc. develops surgical devices for urological and gynecological disorders. It offers UroLift System, a minimally invasive device to treat lower urinary tract symptoms due to benign prostatic hyperplasia. The company was founded by Joshua Makower, Joseph Catanese, Theodore C. Lamson and Earl A. Bright II in 2004 and is headquartered in Pleasanton, CA. | Biotechnology | Director of Finance/CFO Director/Board Member | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Chairman Director/Board Member | |
Panjiva, Inc.
 Panjiva, Inc. Internet Software/ServicesTechnology Services Panjiva, Inc. provides intelligence platform for global trade professionals. Its products include technology, intelligence platform, enterprise and application programming interface. The firm provides solutions for buyer, suppliers, logistics, governments and analysts. The company was founded by Josh Green and James Psota on September 28, 2006 and is headquartered in New York, NY. | Internet Software/Services | Chief Tech/Sci/R&D Officer | |
| FLEXION THERAPEUTICS, INC. | Pharmaceuticals: Major | General Counsel | |
| University of Pennsylvania | College/University | Corporate Officer/Principal Undergraduate Degree | |
| VMWARE, INC. | Packaged Software | Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Graduate Degree Masters Business Admin | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Undergraduate Degree Undergraduate Degree | |
| Indiana University | College/University | Masters Business Admin Undergraduate Degree | |
| Yale University | College/University | Undergraduate Degree Doctorate Degree | |
| Purdue University | College/University | Corporate Officer/Principal Graduate Degree | |
| University of Wisconsin | College/University | Undergraduate Degree Doctorate Degree | |
| The Rockefeller University | College/University | Doctorate Degree | |
| State University of New York at Binghamton | College/University | Undergraduate Degree | |
The Royal Society of Medicine
 The Royal Society of Medicine Miscellaneous Commercial ServicesCommercial Services The Royal Society of Medicine provides postgraduate medical education. The Society provides a range of educational activities and opportunities for doctors, dentists and veterinary surgeons, including students, and for allied healthcare professionals. It also promotes an exchange of information and ideas on the science, practice and organization of medicine, both within the health professions and with responsible and informed public opinion. The Society was founded in 1805 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Organon Laboratories Ltd.
 Organon Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Organon Laboratories Ltd. is a company based in Hoddesdon, UK. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Carmot Therapeutics, Inc.
 Carmot Therapeutics, Inc. BiotechnologyHealth Technology Carmot Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of therapeutics for metabolic diseases, cancer, and inflammation. Its pipeline includes CT-388, CT-996, and CT-868. The CT-388 refers to treatment taken once-weekly subcutaneous injectable for obesity and type 2 diabetes (T2D). The CT-996 comprises of once-daily oral treatment for obesity and T2D. The CT-868 consists of once-daily subcutaneous injectable for treatment of type 1 diabetes (T1D) patients with overweight or obesity. The company was founded in 2008 and is headquartered in Berkeley, CA. | Biotechnology | Director/Board Member | |
| St. George's University of London | College/University | Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| The Fuqua School of Business | College/University | Director/Board Member Masters Business Admin | |
| MINERVA NEUROSCIENCES, INC. | Pharmaceuticals: Major | General Counsel | |
| Washington University School of Law | College/University | Graduate Degree | |
Cambridge Innovation Capital Ltd
 Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital Ltd (Cambridge Innovation Capital) is a venture capital firm founded in 2013. The firm is headquartered in Cambridge, United Kingdom. | Investment Managers | Consultant / Advisor | |
| SIO GENE THERAPIES INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| EARGO, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Pharmaceuticals: Major | Chairman | |
Myovant Sciences, Inc.
 Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Myovant Sciences, Inc. offers therapeutics for women's health and prostate cancer. The company is headquartered in New York, NY. | Medical Specialties | Director/Board Member | |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal President Director of Finance/CFO | |
Urovant Sciences, Inc.
 Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Pharmaceuticals: Major | Director/Board Member | |
Genevant Sciences Corp.
 Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Pharmaceuticals: Major | Chairman | |
New Enterprise Associates LLC
 New Enterprise Associates LLC Investment ManagersFinance New Enterprise Associates LLC is an alternative investment manager. The private company is based in Timonium, MD. The company was founded in 1978 by Chuck Newhall, C. Richard Kramlich. | Investment Managers | Corporate Officer/Principal | |
MapLight Therapeutics, Inc.
 MapLight Therapeutics, Inc. BiotechnologyHealth Technology MapLight Therapeutics, Inc. engages in the development of novel therapeutics for brain disorders. The company is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
Ophirex, Inc.
 Ophirex, Inc. Miscellaneous Commercial ServicesCommercial Services Ophirex, Inc. develops antidotes to snakebite. The company was founded by Jerry D. Harrison and Matthew Lewin and is headquartered in Corte Madera, CA. | Miscellaneous Commercial Services | Chairman | |
Respivant Sciences, Inc.
 Respivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Respivant Sciences, Inc. is a clinical-stage biopharmaceutical company that develops therapies for patients with respiratory diseases. The company is based in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Dermavant Sciences Ltd.
 Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
Aruvant Sciences, Inc.
 Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Aruvant Sciences, Inc. operates as a clinical-stage biopharmaceutical company. The firm develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning. It's lead candidate ARU-1801, is a modified fetal hemoglobin gene therapy for sickle cell disease and related hemoglobinopathies. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Immunovant Sciences Ltd.
 Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chairman Director/Board Member | |
Flexion, Inc.
 Flexion, Inc. Information Technology ServicesTechnology Services Flexion, Inc. is an American company that offers services to help businesses with digital transformation, innovative development, and modernization. The private company provides IT staffing and work to improve the efficiency, security, and user experience of their clients' systems. Flexion uses a rigorous agile practice to build flexible solutions that enable their clients' businesses to grow. | Information Technology Services | General Counsel | |
Gate Neurosciences, Inc.
 Gate Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Gate Neurosciences, Inc. engages in the provision of pharmaceutical services. The company is headquartered in Carmel, IN. | Pharmaceuticals: Major | Founder | |
| Futuristic Labs, Inc. | Chief Executive Officer |
Statistieken
Internationaal
| Verenigde Staten | 44 |
| Verenigd Koninkrijk | 6 |
| Canada | 2 |
| Bermuda | 2 |
Sectoraal
| Health Technology | 27 |
| Consumer Services | 13 |
| Technology Services | 6 |
| Commercial Services | 4 |
| Finance | 4 |
Operationeel
| Director/Board Member | 105 |
| Corporate Officer/Principal | 65 |
| Undergraduate Degree | 28 |
| Director of Finance/CFO | 23 |
| Independent Dir/Board Member | 23 |
Sterkste connecties
| Insiders | |
|---|---|
| Frank Torti | 35 |
| Atul Pande | 20 |
| George Migausky | 18 |
| Andrew Fromkin | 16 |
| Alpheus Bingham | 16 |
| Douglas Hughes | 15 |
| Rita Jain | 14 |
| Timothy Garnett | 13 |
| Thomas W. Grein | 13 |
| Andrew Dahlem | 13 |
| Thomas Petzinger | 12 |
| Eric Venker | 12 |
| Peter Salzmann | 10 |
| Pamela Connealy | 10 |
| Mark Levine | 8 |
- Beurs
- Insiders
- William L. Macias
- Bedrijfsconnecties
